PhaseII,Open-label,Pilot Study Evaluating the Safety+Efficacy of Certican in the Prevention of Chronic Graft-versus-host Disease+Late Pulmonary Complications After Allogeneic Hematopoietic Cell Transplantation Blood.
Phase of Trial: Phase II
Latest Information Update: 12 Jun 2017
At a glance
- Drugs Everolimus (Primary) ; Ciclosporin; Prednisone
- Indications Graft-versus-host disease
- Focus Adverse reactions; Therapeutic Use
- 17 Feb 2017 Status changed from recruiting to completed.
- 14 Apr 2012 New source identified and integrated (European Clinical Trials Database record EudraCT2010-023630-24).
- 19 Jan 2012 New trial record